Cargando…

Epiplakin1 promotes the progression of esophageal squamous cell carcinoma by activating the PI3K‐AKT signaling pathway

BACKGROUND: Epiplakin1 (EPPK1) has been associated with disease progression and unfavorable prognosis of many cancers, but its functional involvement in esophageal squamous cell carcinoma (ESCC) remains to be uncovered. METHODS: The Quantitative Real‐time PCR (qPCR) assay was employed to determine t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qiao, Zhongshi, Dai, Chengcheng, Wang, Zhiqian, Wang, Zifan, Wang, Zheng, Zhang, Tongsong, Niu, Wenjing, Ma, Xuezhen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013648/ https://www.ncbi.nlm.nih.gov/pubmed/35238170 http://dx.doi.org/10.1111/1759-7714.14366

Ejemplares similares

Effects of epiplakin-knockdown in cultured corneal epithelial cells
por: Kokado, Masahide, et al.
Publicado: (2016)

Comparative genomics reveals evolutionary loss of epiplakin in cetaceans
por: Fuchs, Peter, et al.
Publicado: (2022)

Serum Epiplakin Might Be a Potential Serodiagnostic Biomarker for Bladder Cancer
por: Shimura, Soichiro, et al.
Publicado: (2021)

Epiplakin attenuates experimental mouse liver injury by chaperoning keratin reorganization
por: Szabo, Sandra, et al.
Publicado: (2015)

ET-1 promotes the growth and metastasis of esophageal squamous cell carcinoma via activating PI3K/Akt pathway
por: Yin, Hui, et al.
Publicado: (2020)

CEP55 promotes the proliferation, migration and invasion of esophageal squamous cell carcinoma via the PI3K/Akt pathway
por: Jia, Yang, et al.
Publicado: (2018)

Astilbin-induced inhibition of the PI3K/AKT signaling pathway decelerates the progression of osteoarthritis
por: Chen, Chunlin, et al.
Publicado: (2020)

Urokinase plasminogen activator secreted by cancer-associated fibroblasts induces tumor progression via PI3K/AKT and ERK signaling in esophageal squamous cell carcinoma
por: Tian, Baoqing, et al.
Publicado: (2017)

Epiplakin Deficiency Aggravates Murine Caerulein-Induced Acute Pancreatitis and Favors the Formation of Acinar Keratin Granules
por: Wögenstein, Karl L., et al.
Publicado: (2014)

PLCD3 promotes malignant cell behaviors in esophageal squamous cell carcinoma via the PI3K/AKT/P21 signaling
por: Wang, Mengmeng, et al.
Publicado: (2023)

Baicalein induces apoptosis in esophageal squamous cell carcinoma cells through modulation of the PI3K/Akt pathway
por: ZHANG, HONG-BO, et al.
Publicado: (2013)

HMGB1 induces radioresistance through PI3K/AKT/ATM pathway in esophageal squamous cell carcinoma
por: Zhang, Xueyuan, et al.
Publicado: (2022)

Hinokiflavone Inhibits Growth of Esophageal Squamous Cancer By Inducing Apoptosis via Regulation of the PI3K/AKT/mTOR Signaling Pathway
por: Guo, Jida, et al.
Publicado: (2022)

YBX1 promotes tumor progression via the PI3K/AKT signaling pathway in laryngeal squamous cell carcinoma
por: Zhao, Jing, et al.
Publicado: (2021)

HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway
por: Wang, Hongqiang, et al.
Publicado: (2019)

The Expression and Prognostic Impact of the PI3K/AKT/mTOR Signaling Pathway in Advanced Esophageal Squamous Cell Carcinoma
por: Wu, Ning, et al.
Publicado: (2018)

Corrigendum: Hinokiflavone Inhibits Growth of Esophageal Squamous Cancer By Inducing Apoptosis via Regulation of the PI3K/AKT/mTOR Signaling Pathway
por: Guo, Jida, et al.
Publicado: (2022)

Phosphorylation of AKT by lysyl oxidase-like 2 activates the PI3K/AKT signaling pathway to promote proliferation, invasion and metastasis in esophageal squamous carcinoma
por: Fan, Zhiqin, et al.
Publicado: (2023)

A Ca(2+)-Mediated Switch of Epiplakin from a Diffuse to Keratin-Bound State Affects Keratin Dynamics
por: Ratajczyk, Sonia, et al.
Publicado: (2022)

Research progress on the PI3K/AKT signaling pathway in gynecological cancer
por: Shi, Xiang, et al.
Publicado: (2019)

Knockdown of DEAD-box 51 inhibits tumor growth of esophageal squamous cell carcinoma via the PI3K/AKT pathway
por: Hu, Dong-Xin, et al.
Publicado: (2022)

Atractylenolide III Ameliorates Bile Duct Ligation-Induced Liver Fibrosis by Inhibiting the PI3K/AKT Pathway and Regulating Glutamine Metabolism
por: Wang, Yan, et al.
Publicado: (2023)

PLEK2 promotes osteosarcoma tumorigenesis and metastasis by activating the PI3K/AKT signaling pathway
por: Liu, Yang, et al.
Publicado: (2021)

Dihydroartemisinin Inhibits the Proliferation of Esophageal Squamous Cell Carcinoma Partially by Targeting AKT1 and p70S6K
por: Zhu, Lili, et al.
Publicado: (2020)

Significance of PI3K/AKT signaling pathway in metastasis of esophageal squamous cell carcinoma and its potential as a target for anti-metastasis therapy
por: Li, Bin, et al.
Publicado: (2017)

Cancer-associated fibroblasts-derived exosomal miR-3656 promotes the development and progression of esophageal squamous cell carcinoma via the ACAP2/PI3K-AKT signaling pathway
por: Jin, Yuan, et al.
Publicado: (2021)

Long Non-Coding RNA LINC01572 Promotes Hepatocellular Carcinoma Progression via Sponging miR-195-5p to Enhance PFKFB4-Mediated Glycolysis and PI3K/AKT Activation
por: Lai, Shihui, et al.
Publicado: (2021)

MiR-495 inhibits esophageal squamous cell carcinoma progression by targeting Akt1
por: Mao, Yu, et al.
Publicado: (2016)

NETO2 promotes esophageal cancer progression by inducing proliferation and metastasis via PI3K/AKT and ERK pathway
por: Xu, Jia-cheng, et al.
Publicado: (2021)

Capilliposide C Sensitizes Esophageal Squamous Carcinoma Cells to Oxaliplatin by Inducing Apoptosis Through the PI3K/Akt/mTOR Pathway
por: Shen, Zhipeng, et al.
Publicado: (2017)

miR-145 sensitizes esophageal squamous cell carcinoma to cisplatin through directly inhibiting PI3K/AKT signaling pathway
por: Zheng, Tian-Liang, et al.
Publicado: (2019)

XPD inhibits cell growth and invasion and enhances chemosensitivity in esophageal squamous cell carcinoma by regulating the PI3K/AKT signaling pathway
por: Jian, Jie, et al.
Publicado: (2020)

PI3K/Akt/mTOR Signaling Pathway: Role in Esophageal Squamous Cell Carcinoma, Regulatory Mechanisms and Opportunities for Targeted Therapy
por: Luo, Qian, et al.
Publicado: (2022)

Silencing UHRF1 Enhances Radiosensitivity of Esophageal Squamous Cell Carcinoma by Inhibiting the PI3K/Akt/mTOR Signaling Pathway
por: Hui, Beina, et al.
Publicado: (2021)

Tollip promotes hepatocellular carcinoma progression via PI3K/AKT pathway
por: Huang, Lu, et al.
Publicado: (2022)

Preoperative Oral Carbohydrate Improved Postoperative Insulin Resistance in Rats through the PI3K/AKT/mTOR Pathway
por: Wang, Zhiguo, et al.
Publicado: (2015)

AKR1C2 acts as a targetable oncogene in esophageal squamous cell carcinoma via activating PI3K/AKT signaling pathway
por: Zhang, Zhan‐Fei, et al.
Publicado: (2020)

Epigenetic silencing of IGFBPL1 promotes esophageal cancer growth by activating PI3K-AKT signaling
por: Liu, Yingge, et al.
Publicado: (2020)

LSD1 regulates Notch and PI3K/Akt/mTOR pathways through binding the promoter regions of Notch target genes in esophageal squamous cell carcinoma
por: Hou, Guiqin, et al.
Publicado: (2019)

Pterostilbene inhibits gallbladder cancer progression by suppressing the PI3K/Akt pathway
por: Tong, Chenhao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6c126tuta4jqth0eb2upok1cr4